Literature DB >> 27320924

Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells.

Hann Low1, Nigora Mukhamedova1, Huanhuan L Cui2, Brian P McSharry3, Selmir Avdic3, Anh Hoang1, Michael Ditiatkovski1, Yingying Liu1, Ying Fu1, Peter J Meikle1, Martin Blomberg1, Konstantinos A Polyzos4, William E Miller5, Piotr Religa4, Michael Bukrinsky6, Cecilia Soderberg-Naucler4, Barry Slobedman3, Dmitri Sviridov7.   

Abstract

Cytomegalovirus (HCMV) contains cholesterol, but how HCMV interacts with host cholesterol metabolism is unknown. We found that, in human fibroblasts, HCMV infection increased the efflux of cellular cholesterol, despite reducing the abundance of ABCA1. Mechanistically, viral protein US28 was acting through CDC42, rearranging actin microfilaments, causing association of actin with lipid rafts, and leading to a dramatic change in the abundance and/or structure of lipid rafts. These changes displaced ABCA1 from the cell surface but created new binding sites for apolipoprotein A-I, resulting in enhanced cholesterol efflux. The changes also reduced the inflammatory response in macrophages. HCMV infection modified the host lipidome profile and expression of several genes and microRNAs involved in cholesterol metabolism. In mice, murine CMV infection elevated plasma triglycerides but did not affect the level and functionality of high-density lipoprotein. Thus, HCMV, through its protein US28, reorganizes lipid rafts and disturbs cell cholesterol metabolism.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27320924      PMCID: PMC5389417          DOI: 10.1016/j.celrep.2016.05.070

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  33 in total

Review 1.  Virus-encoded G-protein-coupled receptors: constitutively active (dys)regulators of cell function and their potential as drug target.

Authors:  H F Vischer; J W Hulshof; I J P de Esch; M J Smit; R Leurs
Journal:  Ernst Schering Found Symp Proc       Date:  2006

Review 2.  Chemokines and chemokine receptors encoded by cytomegaloviruses.

Authors:  P S Beisser; H Lavreysen; C A Bruggeman; C Vink
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

3.  Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus.

Authors:  M F Stinski
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

4.  Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivity.

Authors:  Nicole Gudleski-O'Regan; Todd M Greco; Ileana M Cristea; Thomas Shenk
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

5.  Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.

Authors:  Liyan Zhuang; Jayoung Kim; Rosalyn M Adam; Keith R Solomon; Michael R Freeman
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

6.  Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae).

Authors:  D Sviridov; N Fidge; G Beaumier-Gallon; C Fielding
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

7.  Alteration of lipid metabolism in cells infected with human cytomegalovirus.

Authors:  Veronica Sanchez; Jennifer J Dong
Journal:  Virology       Date:  2010-08-15       Impact factor: 3.616

8.  Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells.

Authors:  Laura K Juckem; Karl W Boehme; Adam L Feire; Teresa Compton
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

9.  High-density lipoprotein reduces the human monocyte inflammatory response.

Authors:  Andrew J Murphy; Kevin J Woollard; Anh Hoang; Nigora Mukhamedova; Roslynn A Stirzaker; Sally P A McCormick; Alan T Remaley; Dmitri Sviridov; Jaye Chin-Dusting
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

10.  Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells.

Authors:  Luciano Potena; Giada Frascaroli; Francesco Grigioni; Tiziana Lazzarotto; Gaia Magnani; Luciana Tomasi; Fabio Coccolo; Liliana Gabrielli; Carlo Magelli; Maria P Landini; Angelo Branzi
Journal:  Circulation       Date:  2004-01-26       Impact factor: 29.690

View more
  26 in total

Review 1.  Cdc42 - A tryst between host cholesterol metabolism and infection.

Authors:  Dmitri Sviridov; Nigora Mukhamedova
Journal:  Small GTPases       Date:  2016-08-31

Review 2.  Lipid rafts and pathogens: the art of deception and exploitation.

Authors:  Michael I Bukrinsky; Nigora Mukhamedova; Dmitri Sviridov
Journal:  J Lipid Res       Date:  2019-10-15       Impact factor: 5.922

3.  Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood.

Authors:  Ryunosuke Ohkawa; Hann Low; Nigora Mukhamedova; Ying Fu; Shao-Jui Lai; Mai Sasaoka; Ayuko Hara; Azusa Yamazaki; Takahiro Kameda; Yuna Horiuchi; Peter J Meikle; Gerard Pernes; Graeme Lancaster; Michael Ditiatkovski; Paul Nestel; Boris Vaisman; Denis Sviridov; Andrew Murphy; Alan T Remaley; Dmitri Sviridov; Minoru Tozuka
Journal:  J Lipid Res       Date:  2020-09-09       Impact factor: 5.922

Review 4.  Inflammaging and Osteoarthritis.

Authors:  Francesca Motta; Elisa Barone; Antonio Sica; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-18       Impact factor: 8.667

5.  Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction.

Authors:  Michael Ditiatkovski; Nigora Mukhamedova; Dragana Dragoljevic; Anh Hoang; Hann Low; Tatiana Pushkarsky; Ying Fu; Irena Carmichael; Andrew F Hill; Andrew J Murphy; Michael Bukrinsky; Dmitri Sviridov
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

6.  The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication.

Authors:  Beatrice Mercorelli; Anna Luganini; Marta Celegato; Giorgio Palù; Giorgio Gribaudo; Galina I Lepesheva; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

7.  Cholesterol Efflux-Independent Modification of Lipid Rafts by AIBP (Apolipoprotein A-I Binding Protein).

Authors:  Hann Low; Nigora Mukhamedova; Luciano Dos Santos Aggum Capettini; Yining Xia; Irena Carmichael; Stephen H Cody; Kevin Huynh; Michael Ditiatkovski; Ryunosuke Ohkawa; Michael Bukrinsky; Peter J Meikle; Soo-Ho Choi; Seth Field; Yury I Miller; Dmitri Sviridov
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-08-13       Impact factor: 8.311

Review 8.  Overview of Human Cytomegalovirus Pathogenesis.

Authors:  Heather L Fulkerson; Maciej T Nogalski; Donna Collins-McMillen; Andrew D Yurochko
Journal:  Methods Mol Biol       Date:  2021

9.  Low-Density Lipoprotein Receptor Suppresses the Endogenous Cholesterol Synthesis Pathway To Oppose Gammaherpesvirus Replication in Primary Macrophages.

Authors:  C A Aurubin; D A Knaack; D Sahoo; V L Tarakanova
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

10.  Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.

Authors:  Amanda M Casto; Sachiko Seo; David M Levine; Barry E Storer; Xinyuan Dong; John A Hansen; Michael Boeckh; Paul J Martin
Journal:  Blood       Date:  2021-10-28       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.